These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7069595)

  • 1. Antitumor agents XLV: Bisbrusatolyl and brusatolyl esters and related compounds as novel potent antileukemic agents.
    Lee KH; Okano M; Hall IH; Brent DA; Soltmann B
    J Pharm Sci; 1982 Mar; 71(3):338-45. PubMed ID: 7069595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor agents XLVIII: Structure-activity relationships of quassinoids as in vitro protein synthesis inhibitors of P-388 lymphocytic leukemia tumor cell metabolism.
    Liou YF; Hall IH; Okano M; Lee KH; Chaney SG
    J Pharm Sci; 1982 Apr; 71(4):430-5. PubMed ID: 7086652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor agents XLVI: In vitro effects of esters of brusatol, bisbrusatol, and related compounds on nucleic acid and protein synthesis of P-388 lymphocytic leukemia cells.
    Hall IH; Liou YF; Okano M; Lee KH
    J Pharm Sci; 1982 Mar; 71(3):345-8. PubMed ID: 7069596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor agents XLII: Comparison of antileukemic activity of helenalin, brusatol, and bruceantin and their esters on different strains of P-388 lymphocytic leukemic cells.
    Hall IH; Lee KH; Okano M; Sims D; Ibuka T; Liou YF; Imakura Y
    J Pharm Sci; 1981 Oct; 70(10):1147-50. PubMed ID: 7299649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial agents, 4. Synthesis of a brusatol analog and biological activity of brusatol-related compounds.
    Lee KH; Tani S; Imakura Y
    J Nat Prod; 1987; 50(5):847-51. PubMed ID: 3325613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soularubinone, a new antileukemic quassionoid from Soulamea tomentosa.
    Van Tri M; Polonsky J; Merienne C; Sevenet T
    J Nat Prod; 1981; 44(3):279-84. PubMed ID: 7264678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor agents XLVII: The effects of bisbrusatolyl malonate on P-388 lymphocytic leukemia cell metabolism.
    Hall IH; Liou YF; Lee KH; Okano M; Chaney SG
    J Pharm Sci; 1982 Feb; 71(2):257-62. PubMed ID: 6278124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitumor agents. 39. Bruceantinoside-A and -B, novel antileukemic quassinoid glucosides from Brucea antidysenterica.
    Okano M; Lee KH; Hall IH
    J Nat Prod; 1981; 44(4):470-4. PubMed ID: 7288443
    [No Abstract]   [Full Text] [Related]  

  • 9. Quassinoid bitter principles. II.
    Polonsky J
    Fortschr Chem Org Naturst; 1985; 47():221-64. PubMed ID: 3896993
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor agents LIX: effects of quassinoids on protein synthesis of a number of murine tumors and normal cells.
    Hall IH; Liou YF; Lee KH; Chaney SG; Willingham W
    J Pharm Sci; 1983 Jun; 72(6):626-30. PubMed ID: 6875823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural requirements for biological activity among antileukemic glaucarubolone ester quassinoids.
    Kupchan SM; Lacadie JA; Howie GA; Sickles BR
    J Med Chem; 1976 Sep; 19(9):1130-3. PubMed ID: 978677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor agents. XXXV: Effects of brusatol, bruceoside A, and bruceantin on P-388 lymphocytic leukemia cell respiration.
    Eigebaly SA; Hall IH; Lee KH; Sumida Y; Imakura Y; Wu RY
    J Pharm Sci; 1979 Jul; 68(7):887-90. PubMed ID: 222889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
    Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
    Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antineoplastic quassinoids of Simaba cuspidata spruce and Ailanthus grandis Prain.
    Polonsky J; Varon Z; Moretti C; Pettit GR; Herald CL; Rideout JA; Saha SB; Khastgir HN
    J Nat Prod; 1980; 43(4):503-9. PubMed ID: 7431025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel esters of glaucarubolone as inducers of terminal differentiation of promyelocytic HL-60 cells and inhibitors of 7,12-dimethylbenz[a]anthracene-induced preneoplastic lesion formation in mouse mammary organ culture.
    Mata-Greenwood E; Daeuble JF; Grieco PA; Dou J; McChesney JD; Mehta RG; Kinghorn AD; Pezzuto JM
    J Nat Prod; 2001 Dec; 64(12):1509-13. PubMed ID: 11754601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agents, 118. The isolation and characterization of bruceanic acid A, its methyl ester, and the new bruceanic acids B, C, and D, from Brucea antidysenterica.
    Toyota T; Fukamiya N; Okano M; Tagahara K; Chang JJ; Lee KH
    J Nat Prod; 1990; 53(6):1526-32. PubMed ID: 2089121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plants as sources of antimalarial drugs: in vitro antimalarial activities of some quassinoids.
    O'Neill MJ; Bray DH; Boardman P; Phillipson JD; Warhurst DC; Peters W; Suffness M
    Antimicrob Agents Chemother; 1986 Jul; 30(1):101-4. PubMed ID: 3530122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of cytotoxic fluorinated quassinoids.
    Ohno N; Fukamiya N; Okano M; Tagahara K; Lee KH
    Bioorg Med Chem; 1997 Aug; 5(8):1489-95. PubMed ID: 9313855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-inflammatory agents III: Structure-activity relationships of brusatol and related quassinoids.
    Hall IH; Lee KH; Imakura Y; Okano M; Johnson A
    J Pharm Sci; 1983 Nov; 72(11):1282-4. PubMed ID: 6417321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor agents, 90. Bruceantinoside C, a new cytotoxic quassinoid glycoside from Brucea antidysenterica.
    Fukamiya N; Okano M; Tagahara K; Aratani T; Muramoto Y; Lee KH
    J Nat Prod; 1987; 50(6):1075-9. PubMed ID: 3443857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.